Evidence map›Paper›PMID 29262868›Full record

ArticleMicrobiome2017

Quinones are growth factors for the human gut microbiota.

Kathrin Fenn, Philip Strandwitz, Eric J Stewart, Eric Dimise, Sarah Rubin, Shreya Gurubacharya, Jon Clardy, Kim Lewis

Open access · goldAbstract read
In one paragraph

Article in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Anaerobic riboflavin degradation by human gutJournal of bacteriology · 2026
    Article
  6. Article
  7. Article
  8. Anaerobic riboflavin degradation by human gutbioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Biofilm development ofMicrobiology spectrum · 2025
    Article
  12. Disulphide bond-forming enzymes in clostridial species.Microbiology (Reading, England) · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kathrin FennAntimicrobial Discovery Center, Department of Biology, Northeastern University, 134 Mugar Hall, 360 Huntington Ave, Boston, MA, 02115, USA.
Philip StrandwitzAntimicrobial Discovery Center, Department of Biology, Northeastern University, 134 Mugar Hall, 360 Huntington Ave, Boston, MA, 02115, USA.
Eric J StewartAntimicrobial Discovery Center, Department of Biology, Northeastern University, 134 Mugar Hall, 360 Huntington Ave, Boston, MA, 02115, USA.
Eric DimiseDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
Sarah RubinAntimicrobial Discovery Center, Department of Biology, Northeastern University, 134 Mugar Hall, 360 Huntington Ave, Boston, MA, 02115, USA.
Shreya GurubacharyaAntimicrobial Discovery Center, Department of Biology, Northeastern University, 134 Mugar Hall, 360 Huntington Ave, Boston, MA, 02115, USA.
Jon ClardyDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
Kim LewisAntimicrobial Discovery Center, Department of Biology, Northeastern University, 134 Mugar Hall, 360 Huntington Ave, Boston, MA, 02115, USA. k.lewis@neu.edu.
Northeastern University · USHarvard University · USWeizmann Institute of Science · IL

Funding

Culturing Uncultivatable Gut MicroorganismsR01HG005824 · NHGRI · NORTHEASTERN UNIVERSITY · PI LEWIS, KIM · 2010 to 2012
$1.4M
Chemical biology of bacterial symbiontsR01AT009874 · NCCIH · HARVARD MEDICAL SCHOOL · PI CLARDY, JON · 2017 to 2019
$1.2M
NCCIH NIH HHS R01 AT009874NHGRI NIH HHS R01 HG005824NIH HHS R01GM086158NIH HHS R01HG005824
6 · The paper itself

Abstract

backgroundThe human gut microbiome has been linked to numerous components of health and disease. However, approximately 25% of the bacterial species in the gut remain uncultured, which limits our ability to properly understand, and exploit, the human microbiome. Previously, we found that growing environmental bacteria in situ in a diffusion chamber enables growth of uncultured species, suggesting the existence of growth factors in the natural environment not found in traditional cultivation media. One source of growth factors proved to be neighboring bacteria, and by using co-culture, we isolated previously uncultured organisms from the marine environment and identified siderophores as a major class of bacterial growth factors. Here, we employ similar co-culture techniques to grow bacteria from the human gut microbiome and identify novel growth factors.

resultsBy testing dependence of slow-growing colonies on faster-growing neighboring bacteria in a co-culture assay, eight taxonomically diverse pairs of bacteria were identified, in which an "induced" isolate formed a gradient of growth around a cultivatable "helper." This set included two novel species Faecalibacterium sp. KLE1255-belonging to the anti-inflammatory Faecalibacterium genus-and Sutterella sp. KLE1607. While multiple helper strains were identified, Escherichia coli was also capable of promoting growth of all induced isolates. Screening a knockout library of E. coli showed that a menaquinone biosynthesis pathway was required for growth induction of Faecalibacterium sp. KLE1255 and other induced isolates. Purified menaquinones induced growth of 7/8 of the isolated strains, quinone specificity profiles for individual bacteria were identified, and genome analysis suggests an incomplete menaquinone biosynthetic capability yet the presence of anaerobic terminal reductases in the induced strains, indicating an ability to respire anaerobically.

conclusionsOur data show that menaquinones are a major class of growth factors for bacteria from the human gut microbiome. These organisms are taxonomically diverse, including members of the genus Faecalibacterium, Bacteroides, Bilophila, Gordonibacter, and Sutterella. This suggests that loss of quinone biosynthesis happened independently in many lineages of the human microbiota. Quinones can be used to improve existing bacterial growth media or modulate the human gut microbiota by encouraging the growth of important symbionts, such as Faecalibacterium species.

Indexed as

ActinobacteriaBacteriaBacterial Physiological PhenomenaBacteriological TechniquesCoculture TechniquesEscherichia coliFaecalibacteriumFecesGastrointestinal MicrobiomeHumansIntercellular Signaling Peptides and ProteinsPhylogenySiderophoresUbiquinoneVitamin K 2Intercellular Signaling Peptides and ProteinsSiderophoresUbiquinoneVitamin K 2CultivationFaecalibacteriumGrowth factorsMenaquinonesMicrobiomeUncultured bacteria

Identifiers

PMID29262868
PMCPMC5738691
OpenAlexW2779674499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.